148 related articles for article (PubMed ID: 12761259)
1. Predictors of renal and patient outcomes in atheroembolic renal disease: a prospective study.
Scolari F; Ravani P; Pola A; Guerini S; Zubani R; Movilli E; Savoldi S; Malberti F; Maiorca R
J Am Soc Nephrol; 2003 Jun; 14(6):1584-90. PubMed ID: 12761259
[TBL] [Abstract][Full Text] [Related]
2. Cholesterol crystal embolism: A recognizable cause of renal disease.
Scolari F; Tardanico R; Zani R; Pola A; Viola BF; Movilli E; Maiorca R
Am J Kidney Dis; 2000 Dec; 36(6):1089-109. PubMed ID: 11096032
[TBL] [Abstract][Full Text] [Related]
3. The challenge of diagnosing atheroembolic renal disease: clinical features and prognostic factors.
Scolari F; Ravani P; Gaggi R; Santostefano M; Rollino C; Stabellini N; Colla L; Viola BF; Maiorca P; Venturelli C; Bonardelli S; Faggiano P; Barrett BJ
Circulation; 2007 Jul; 116(3):298-304. PubMed ID: 17606842
[TBL] [Abstract][Full Text] [Related]
4. [Atheroembolic renal disease: analysis of clinical and therapeutic factors that influence its progression].
Gutiérrez Solís E; Morales E; Rodríguez Jornet A; Andreu FJ; Rivera F; Vozmediano C; Gutiérrez E; Igarzábal A; Enguita AB; Praga M
Nefrologia; 2010; 30(3):317-23. PubMed ID: 20414329
[TBL] [Abstract][Full Text] [Related]
5. The evolution of renal function and the incidence of end-stage renal disease in patients aged ≥ 50 years.
Van Pottelbergh G; Bartholomeeusen S; Buntinx F; Degryse J
Nephrol Dial Transplant; 2012 Jun; 27(6):2297-303. PubMed ID: 22102615
[TBL] [Abstract][Full Text] [Related]
6. Subclinical Kidney Damage in Hypertensive Patients: A Renal Window Opened on the Cardiovascular System. Focus on Microalbuminuria.
Mulè G; Castiglia A; Cusumano C; Scaduto E; Geraci G; Altieri D; Di Natale E; Cacciatore O; Cerasola G; Cottone S
Adv Exp Med Biol; 2017; 956():279-306. PubMed ID: 27873229
[TBL] [Abstract][Full Text] [Related]
7. Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention.
Parikh PB; Jeremias A; Naidu SS; Brener SJ; Lima F; Shlofmitz RA; Pappas T; Marzo KP; Gruberg L
Catheter Cardiovasc Interv; 2012 Sep; 80(3):352-7. PubMed ID: 22566286
[TBL] [Abstract][Full Text] [Related]
8. Sustained complete renal remission is a predictor of reduced mortality, chronic kidney disease and end-stage renal disease in lupus nephritis.
Pakchotanon R; Gladman DD; Su J; Urowitz MB
Lupus; 2018 Mar; 27(3):468-474. PubMed ID: 28857717
[TBL] [Abstract][Full Text] [Related]
9. Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the multiple risk factor intervention trial.
Ishani A; Grandits GA; Grimm RH; Svendsen KH; Collins AJ; Prineas RJ; Neaton JD
J Am Soc Nephrol; 2006 May; 17(5):1444-52. PubMed ID: 16611715
[TBL] [Abstract][Full Text] [Related]
10. Advanced chronic kidney disease, end-stage renal disease and renal death among HIV-positive individuals in Europe.
Ryom L; Kirk O; Lundgren JD; Reiss P; Pedersen C; De Wit S; Buzunova S; Gasiorowski J; Gatell JM; Mocroft A;
HIV Med; 2013 Sep; 14(8):503-8. PubMed ID: 23590641
[TBL] [Abstract][Full Text] [Related]
11. Genetic variants of the protein kinase C-beta 1 gene and development of end-stage renal disease in patients with type 2 diabetes.
Ma RC; Tam CH; Wang Y; Luk AO; Hu C; Yang X; Lam V; Chan AW; Ho JS; Chow CC; Tong PC; Jia W; Ng MC; So WY; Chan JC
JAMA; 2010 Aug; 304(8):881-9. PubMed ID: 20736472
[TBL] [Abstract][Full Text] [Related]
12. The importance of proteinuria and prior cardiovascular disease in all major clinical outcomes of atherosclerotic renovascular disease - a single-center observational study.
Vassallo D; Ritchie J; Green D; Chrysochou C; Blunt J; Kalra PA
BMC Nephrol; 2016 Dec; 17(1):198. PubMed ID: 27927187
[TBL] [Abstract][Full Text] [Related]
13. Permanent Decline of Renal Function after Infrarenal Abdominal Aortic Aneurysm Repair-Frequency and Risk Factors.
Zabrocki L; Marquardt F; Albrecht K; Kribben A; Herget-Rosenthal S
Ann Vasc Surg; 2018 Feb; 47():272-278. PubMed ID: 28943483
[TBL] [Abstract][Full Text] [Related]
14. Change in novel filtration markers and risk of ESRD.
Rebholz CM; Grams ME; Matsushita K; Selvin E; Coresh J
Am J Kidney Dis; 2015 Jul; 66(1):47-54. PubMed ID: 25542414
[TBL] [Abstract][Full Text] [Related]
15. Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis.
deFilippi C; Wasserman S; Rosanio S; Tiblier E; Sperger H; Tocchi M; Christenson R; Uretsky B; Smiley M; Gold J; Muniz H; Badalamenti J; Herzog C; Henrich W
JAMA; 2003 Jul; 290(3):353-9. PubMed ID: 12865376
[TBL] [Abstract][Full Text] [Related]
16. The effect of increasing age on the prognosis of non-dialysis patients with chronic kidney disease receiving stable nephrology care.
De Nicola L; Minutolo R; Chiodini P; Borrelli S; Zoccali C; Postorino M; Iodice C; Nappi F; Fuiano G; Gallo C; Conte G;
Kidney Int; 2012 Aug; 82(4):482-8. PubMed ID: 22622495
[TBL] [Abstract][Full Text] [Related]
17. A prospective study of the determinants of renal functional outcome and mortality in atherosclerotic renovascular disease.
Wright JR; Shurrab AE; Cheung C; Waldek S; O'Donoghue DJ; Foley RN; Mamtora H; Kalra PA
Am J Kidney Dis; 2002 Jun; 39(6):1153-61. PubMed ID: 12046025
[TBL] [Abstract][Full Text] [Related]
18. Plasma pentosidine is associated with inflammation and malnutrition in end-stage renal disease patients starting on dialysis therapy.
Suliman ME; Heimbürger O; Bárány P; Anderstam B; Pecoits-Filho R; Rodríguez Ayala E; Qureshi AR; Fehrman-Ekholm I; Lindholm B; Stenvinkel P
J Am Soc Nephrol; 2003 Jun; 14(6):1614-22. PubMed ID: 12761263
[TBL] [Abstract][Full Text] [Related]
19. Atheroembolic renal failure requiring dialysis: potential for renal recovery? A review of 43 cases.
Thériault J; Agharazzi M; Dumont M; Pichette V; Ouimet D; Leblanc M
Nephron Clin Pract; 2003; 94(1):c11-8. PubMed ID: 12806187
[TBL] [Abstract][Full Text] [Related]
20. Estimated glomerular filtration rate variability and risk of end-stage renal disease among patients with Stage 3 chronic kidney disease.
Perkins RM; Kirchner HL; Hartle JE; Bucaloiu ID
Clin Nephrol; 2013 Oct; 80(4):256-62. PubMed ID: 23993165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
